# Biomat USA, Inc. – FDA Inspection, Sep 22, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/30d5dfec-bd2a-44b3-9a14-b189f1d51c5e
Source feed: FDA_Inspections

> FDA inspection 1026545 of Biomat USA, Inc., September 22, 2017. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR parts 211 and 606. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026545
- Company Name: Biomat USA, Inc.
- Inspection Date: 2017-09-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 5

## Related Documents

- FDA Inspection 1256167 - 2024-11-15

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/travis-r-hunt/a10b358d-80ac-44af-9c9e-761660db1a53)

Company: https://www.keypedia.com/companies/biomat-usa-inc/050c35c8-a2e3-4c1d-a3c4-15168f2b297c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
